NAD+ Injectable
Good for: Those seeking the highest-bioavailability NAD+ delivery method, particularly those wanting to maximize cellular energy support, cognitive performance, or recovery from training.
Injectable NAD+ delivers nicotinamide adenine dinucleotide directly into the body via subcutaneous injection, bypassing the digestive and metabolic conversion steps required by oral precursors. This produces more direct and reliable increases in circulating NAD+ levels for patients seeking maximum cellular support.
When injected subcutaneously, NAD+ enters circulation and is taken up by cells throughout the body. This bypasses the conversion bottleneck that limits how much oral precursors ultimately translate into usable NAD+. Elevated intracellular NAD+ supports mitochondrial function, activates DNA repair pathways, and regulates metabolic and inflammatory processes associated with aging and cellular stress.
Every batch of compounded medication is third-party tested before it ships. All testing follows USP 797 and the relevant USP chapter for each test. Your provider continues to monitor your treatment, so quality doesn't stop at the pharmacy door.
Explained by our providers
How injectable NAD+ works
NAD+ is central to mitochondrial energy production and cellular repair, and levels decline with age. Injectable NAD+ is delivered subcutaneously, bypassing both digestive processing and the metabolic conversion steps that oral and sublingual formats require. This raises circulating levels faster and more completely than any other delivery format.
What to expect on injectable NAD+
Most patients notice improvements in energy, mental clarity, and physical recovery within 1 to 2 weeks, faster than with sublingual or oral formats. Local injection site reactions are the most common side effect and typically resolve within a day. Your provider checks in on your response regularly and adjusts your protocol based on what you're noticing.
Pay for medicine, not marketing
Not all medications are created equal. Our prescriptions are compounded in the U.S. through our pharmacy partner with decades of experience and strict quality controls.
Ingredient quality
Sterility
Endotoxin
Potency
Our pharmacy partner is:
Inclusive care. Exclusively Haven.
- Born out of a doctor’s office, not a tech company
- Virtual check-ins with board-certified medical providers
- Pay for actual treatment, not subscription fees
Pricing breakdown
This medication may require lab testing that can be completed at a Haven Health or 3rd-party lab location. Your provider will determine what's necessary based on your care plan.
Common questions
Injectable NAD+ has a favorable safety profile when administered subcutaneously at therapeutic doses. It is well-tolerated by most patients. Some experience mild injection site reactions including transient redness or soreness. Intravenous NAD+ infusions have been associated with flushing and chest tightness at rapid infusion rates; subcutaneous injection avoids these concerns by delivering NAD+ more gradually.
Injectable NAD+ is self-administered subcutaneously, typically into the abdomen or outer thigh. Your provider will demonstrate technique and specify your dose, frequency, and injection sites. Most patients inject several times per week. All necessary supplies are included with your prescription.
Many patients report noticeable improvements in energy, mental sharpness, and physical recovery within 1 to 2 weeks of starting injectable NAD+. The injectable format tends to produce more immediate and consistent results than oral or sublingual alternatives. Your provider will check in on your response and adjust your protocol accordingly.
Injectable NAD+ is generally well-tolerated. The most common side effects are local reactions at the injection site, including mild redness, swelling, or tenderness. These typically resolve within a day. Some patients experience brief fatigue or mild nausea immediately after injection, which tends to diminish as the body adjusts to the protocol.
Injectable and intravenous NAD+ have been studied in the context of addiction recovery, neurological support, and metabolic health, with a growing body of research on subcutaneous delivery specifically. Clinical data supports the ability of direct NAD+ administration to raise circulating levels more efficiently than oral precursors. Research in aging populations has shown associations with improved energy metabolism and cognitive function, and the broader NAD+ biology literature continues to expand rapidly.
